Mitogen-activated protein kinase-activated protein kinases 2 and 3 regulate serca2a expression and fiber type composition to modulate skeletal muscle and cardiomyocyte function

Molecular and Cellular Biology

Volumn 33, Issue 13, 2013, Pages 2586-2602

  Scharf, Madeleine ^a   Neef, Stefan ^b   Freund, Robert ^a   Geers Knörr, Cornelia ^a   Franz Wachtel, Mirita ^c   Brandis, Almuth ^a   Krone, Dorothee ^a   Schneider, Heike ^a   Groos, Stephanie ^a   Menon, Manoj B ^a   Chang, Kin Chow ^d   Kraft, Theresia ^a   Meissner, Joachim D ^a   Boheler, Kenneth R ^e,f   Maier, Lars S ^b   Gaestel, Matthias ^a   Scheibe, Renate J ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^e NATIONAL INSTITUTE ON AGING   (United States)

^f UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYOSIN HEAVY CHAIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2A; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GENE; GENE EXPRESSION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILE FORCE; HISTOLOGY; MOUSE; MUSCLE CELL; MUSCLE CONTRACTILITY; MUSCLE FUNCTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REPORTER GENE; SERCA2A GENE; SKELETAL MUSCLE; SOLEUS MUSCLE; UPREGULATION;

ANIMALS; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION REGULATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASE 12; MITOGEN-ACTIVATED PROTEIN KINASE 14; MUSCLE CONTRACTION; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MYOCYTES, CARDIAC; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; TRANS-ACTIVATORS;

EID: 84880653056     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01692-12     Document Type: Article

References (83)

1. Pette D. 2002. The adaptive potential of skeletal muscle fibers. Can. J. Appl. Physiol. 27:423-448.
2. Williams RS, Neufer PD. 1996. Regulation of gene expression in skeletal muscle by contractile activity, p 1124-1150. In Rowell LB, Shepherd JT (ed), Handbook of physiology. Section 12. Exercise: regulation and integration of multiple systems. Oxford University Press, Oxford, United Kingdom.
3. Booth FW, Baldwin KM. 1996. Muscle plasticity: energy demand and supply processes, p 1075-1123. In Rowell LB, Shepherd JT (ed), Handbook of physiology. Section 12. Exercise: regulation and integration of multiple systems. Oxford University Press, Oxford, United Kingdom.
4. Fluck M. 2006. Functional, structural and molecular plasticity of mammalian skeletal muscle in response to exercise stimuli. J. Exp. Biol. 209: 2239-2248.
5. Schiaffino S, Serrano A. 2002. Calcineurin signaling and neural control of skeletal muscle fiber type and size. Trends Pharmacol. Sci. 23:569-575.
6. Bassel-Duby R, Olson EN. 2006. Signaling pathways in skeletal muscle remodeling. Annu. Rev. Biochem. 75:19-37.
7. Clerk A, Cullingford TE, Fuller SJ, Giraldo A, Markou T, Pikkarainen S, Sugden PH. 2007. Signaling pathways mediating cardiac myocyte gene expression in physiological and stress responses. J. Cell. Physiol. 212:311-322.
8. Kemi OJ, WisloffU. 2010. Mechanisms of exercise-induced improvements in the contractile apparatus of the mammalian myocardium. Acta Physiol. (Oxf.) 199:425-439.
9. Cuenda A, Cohen P. 1999. Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis. J. Biol. Chem. 274:4341-4346.
10. Marber MS, Rose B, Wang Y. 2011. The p38 mitogen-activated protein kinase pathway-a potential target for intervention in infarction, hypertrophy, and heart failure. J. Mol. Cell. Cardiol. 51:485-490.
11. Perdiguero E, Ruiz-Bonilla V, Gresh L, Hui L, Ballestar E, Sousa-Victor P, Baeza-Raja B, Jardi M, Bosch-Comas A, Esteller M, Caelles C, Serrano AL, Wagner EF, Munoz-Canoves P. 2007. Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38alpha in abrogating myoblast proliferation. EMBO J. 26:1245-1256.
12. Wang H, Xu Q, Xiao F, Jiang Y, Wu Z. 2008. Involvement of the p38 mitogen-activated protein kinase alpha, beta, and gamma isoforms in myogenic differentiation. Mol. Biol. Cell 19:1519-1528.
13. Puri PL, Wu Z, Zhang P, Wood LD, Bhakta KS, Han J, Feramisco JR, Karin M, Wang JY. 2000. Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes Dev. 14:574-584.
14. Keren A, Tamir Y, Bengal E. 2006. The p38 MAPK signaling pathway: a major regulator of skeletal muscle development. Mol. Cell. Endocrinol. 252:224-230.
15. Ruiz-Bonilla V, Perdiguero E, Gresh L, Serrano AL, Zamora M, Sousa-Victor P, Jardi M, Wagner EF, Munoz-Canoves P. 2008. Efficient adult skeletal muscle regeneration in mice deficient in p38beta, p38gamma and p38delta MAP kinases. Cell Cycle 7:2208-2214.
16. Widegren U, Ryder JW, Zierath JR. 2001. Mitogen-activated protein kinase signal transduction in skeletal muscle: effects of exercise and muscle contraction. Acta Physiol. Scand. 172:227-238.
17. Gaestel M. 2006. MAPKAP kinases-MKs-two's company, three's a crowd. Nat. Rev. Mol. Cell Biol. 7:120-130.
18. Ronkina N, Kotlyarov A, Dittrich-Breiholz O, Kracht M, Hitti E, Milarski K, Askew R, Marusic S, Lin LL, Gaestel M, Telliez JB. 2007. The mitogen-activated protein kinase (MAPK)-activated protein kinases MK2 and MK3 cooperate in stimulation of tumor necrosis factor biosynthesis and stabilization of p38 MAPK. Mol. Cell. Biol. 27:170-181.
19. Kotlyarov A, Neininger A, Schubert C, Eckert R, Birchmeier C, Volk HD, Gaestel M. 1999. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat. Cell Biol. 1:94-97.
20. Streicher JM, Ren S, Herschman H, Wang Y. 2010. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart. Circ. Res. 106:1434-1443.
21. Periasamy M, Kalyanasundaram A. 2007. SERCA pump isoforms: their role in calcium transport and disease. Muscle Nerve 35:430-442.
22. Meyer M, Schillinger W, Pieske B, Holubarsch C, Heilmann C, Posival H, Kuwajima G, Mikoshiba K, Just H, Hasenfuss G. 1995. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 92:778-784.
23. Cerra MC, Imbrogno S. 2011. Phospholamban and cardiac function: a comparative perspective in vertebrates. Acta Physiol. (Oxf.) 205:9-25.
24. Arany Z. 2008. PGC-1 coactivators and skeletal muscle adaptations in health and disease. Curr. Opin. Genet. Dev. 18:426-434.
25. Puigserver P, Spiegelman BM. 2003. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev. 24:78-90.
26. Meissner JD, Umeda PK, Chang KC, Gros G, Scheibe RJ. 2007. Activation of the beta myosin heavy chain promoter by MEF-2D, MyoD, p300, and the calcineurin/NFATc1 pathway. J. Cell. Physiol. 211:138-148.
27. Meissner JD, Freund R, Krone D, Umeda PK, Chang KC, Gros G, Scheibe RJ. 2011. Extracellular signal-regulated kinase 1/2-mediated phosphorylation of p300 enhances myosin heavy chain I/beta gene expression via acetylation of nuclear factor of activated T cells c1. Nucleic Acids Res. 39:5907-5925.
28. Brady M, Koban MU, Dellow KA, Yacoub M, Boheler KR, Fuller SJ. 2003. Sp1 and Sp3 transcription factors are required for trans-activation of the human SERCA2 promoter incardiomyocytes. Cardiovasc. Res. 60: 347-354.
29. 2+)-ATPase (SERCA2) gene promoter. J. Mol. Cell. Cardiol. 28: 2139-2150.
30. Kotlyarov A, Yannoni Y, Fritz S, Laass K, Telliez JB, Pitman D, Lin LL, Gaestel M. 2002. Distinct cellular functions of MK2. Mol. Cell. Biol. 22:4827-4835.
31. Ronkina N, Menon MB, Schwermann J, Arthur JS, Legault H, Telliez JB, Kayyali US, Nebreda AR, Kotlyarov A, Gaestel M. 2011. Stress induced gene expression: a direct role for MAPKAP kinases in transcriptional activation of immediate early genes. Nucleic Acids Res. 39:2503-2518.
32. Raingeaud J, Whitmarsh AJ, Barrett T, Derijard B, Davis RJ. 1996. MKK3-and MKK6-regulated gene expression is mediated by the p38 mitogen- activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16:1247-1255.
33. Ogilvie RW, Feeback DL. 1990. A metachromatic dye-ATPase method for the simultaneous identification of skeletal muscle fiber types I, IIA, IIB and IIC. Stain Technol. 65:231-241.
34. Brooke MH, Kaiser KK. 1970. Three "myosin adenosine triphosphatase" systems: the nature of their pH lability and sulfhydryl dependence. J. Histochem. Cytochem. 18:670-672.
35. Fraysse B, Rouaud T, Millour M, Fontaine-Perus J, Gardahaut MF, Levitsky DO. 2001. Expression of the Na(+)/Ca(2+) exchanger in skeletal muscle. Am. J. Physiol. Cell Physiol. 280:C146-C154.
36. Kubis HP, Gros G. 1997. A rapid electrophoretic method for separating rabbit skeletal muscle myosin heavy chains at high resolution. Electrophoresis18:64-66.
37. Cannon-Carlson S, Tang J. 1997. Modification of the Laemmli sodium dodecyl sulfate-polyacrylamide gel electrophoresis procedure to eliminate artifacts on reducing and nonreducing gels. Anal. Biochem. 246:146-148.
38. Geers C, Gros G. 1990. Effects of carbonic anhydrase inhibitors on contraction, intracellular pH and energy-rich phosphates of rat skeletal muscle. J. Physiol. 423:279-297.
39. Barjaktarovic Z, Schutz W, Madlung J, Fladerer C, Nordheim A, Hampp R. 2009. Changes in the effective gravitational field strength affect the state of phosphorylation of stress-related proteins in callus cultures of Arabidopsis thaliana. J. Exp. Bot. 60:779-789.
40. Goodman T, Schulenberg B, Steinberg TH, Patton WF. 2004. Detection of phosphoproteins on electroblot membranes using a small-molecule organic fluorophore. Electrophoresis 25:2533-2538.
41. Schulenberg B, Goodman TN, Aggeler R, Capaldi RA, Patton WF. 2004. Characterization of dynamic and steady-state protein phosphorylation using a fluorescent phosphoprotein gel stain and mass spectrometry. Electrophoresis 25:2526-2532.
42. Lesuffleur T, Porchet N, Aubert JP, Swallow D, Gum JR, Kim YS, Real FX, Zweibaum A. 1993. Differential expression of the human mucin genes MUC1 to MUC5 in relation to growth and differentiation of different mucus-secreting HT-29 cell subpopulations. J. Cell Sci. 106(Part 3): 771-783.
43. 2++- induced fast-to-slow transition in primary skeletal muscle culture cells at the mRNA level. J. Physiol. 523(Part 1):19-28.
44. Wu KD, Lee WS, Wey J, Bungard D, Lytton J. 1995. Localization and quantification of endoplasmic reticulum Ca(2+)-ATPase isoform transcripts. Am. J. Physiol. 269:C775-C784.
45. Christy BA, Lau LF, Nathans D. 1988. A gene activated in mouse 3T3 cells by serum growth factors encodes a protein with "zinc finger" sequences. Proc. Natl. Acad. Sci. U. S. A. 85:7857-7861.
46. Kadonaga JT, Carner KR, Masiarz FR, Tjian R. 1987. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell 51:1079-1090.
47. Rzeczkowski K, Beuerlein K, Muller H, Dittrich-Breiholz O, Schneider H, Kettner-Buhrow D, Holtmann H, Kracht M. 2011. c-Jun N-terminal kinase phosphorylates DCP1a to control formation of P bodies. J. Cell Biol. 194:581-596.
48. Darby TG, Meissner JD, Ruhlmann A, Mueller WH, Scheibe RJ. 1997. Functional interference between retinoic acid or steroid hormone receptors and the oncoprotein Fli-1. Oncogene 15:3067-3082.
49. Backs J, Backs T, Neef S, Kreusser MM, Lehmann LH, Patrick DM, Grueter CE, Qi X, Richardson JA, Hill JA, Katus HA, Bassel-Duby R, Maier LS, Olson EN. 2009. The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc. Natl. Acad. Sci. U. S. A. 106:2342-2347.
50. 2++ levels in right atrial myocardium of patients with atrial fibrillation. Circ. Res. 106: 1134-1144.
51. Asmussen G, Schmalbruch I, Soukup T, Pette D. 2003. Contractile properties, fiber types, and myosin isoforms in fast and slow muscles of hyperactive Japanese waltzing mice. Exp. Neurol. 184:758-766.
52. Luedeke JD, McCall RD, Dillaman RM, Kinsey ST. 2004. Properties of slow- and fast-twitch skeletal muscle from mice with an inherited capacity for hypoxic exercise. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 138:373-382.
53. Huber B, Pette D. 1996. Dynamics of parvalbumin expression in lowfrequency- stimulated fast-twitch rat muscle. Eur. J. Biochem. 236:814-819.
54. Meissner JD, Chang KC, Kubis HP, Nebreda AR, Gros G, Scheibe RJ. 2007. The p38alpha/beta MAP kinases mediate recruitment of CBP to preserve fast myosin heavy chain IId/x gene activity in myotubes. J. Biol. Chem. 282:7265-7275.
55. Leberer E, Hartner KT, Pette D. 1987. Reversible inhibition of sarcoplasmic reticulum Ca-ATPase by altered neuromuscular activity in rabbit fasttwitch muscle. Eur. J. Biochem. 162:555-561.
56. Gleyzer N, Vercauteren K, Scarpulla RC. 2005. Control of mitochondrial transcription specificity factors (TFB1M and TFB2M) by nuclear respiratory factors (NRF-1 and NRF-2) and PGC-1 family coactivators. Mol. Cell. Biol. 25:1354-1366.
57. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, Lowell BB, Bassel-Duby R, Spiegelman BM. 2002. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418:797-801.
58. Narkar VA, Downes M, Yu RT, Embler E, Wang YX, Banayo E, Mihaylova MM, Nelson MC, Zou Y, Juguilon H, Kang H, Shaw RJ, Evans RM. 2008. AMPK and PPARdelta agonists are exercise mimetics. Cell 134:405-415.
59. Carlson BM. 1968. Regeneration of the completely excised gastrocnemius muscle in the frog and rat from minced muscle fragments. J. Morphol. 125:447-472.
60. Zammit PS, Relaix F, Nagata Y, Ruiz AP, Collins CA, Partridge TA, Beauchamp JR. 2006. Pax7 and myogenic progression in skeletal muscle satellite cells. J. Cell Sci. 119:1824-1832.
61. Gibson MC, Schultz E. 1983. Age-related differences in absolute numbers of skeletal muscle satellite cells. Muscle Nerve 6:574-580.
62. Smith SJ, Fenwick PS, Nicholson AG, Kirschenbaum F, Finney-Hayward TK, Higgins LS, Giembycz MA, Barnes PJ, Donnelly LE. 2006. Inhibitory effect of p38 mitogen-activated protein kinase inhibitors on cytokine release from human macrophages. Br. J. Pharmacol. 149:393-404.
63. Thomas T, Timmer M, Cesnulevicius K, Hitti E, Kotlyarov A, Gaestel M. 2008. MAPKAP kinase 2-deficiency prevents neurons from cell death by reducing neuroinflammation-relevance in a mouse model of Parkinson's disease. J. Neurochem. 105:2039-2052.
64. Babu GJ, Bhupathy P, Timofeyev V, Petrashevskaya NN, Reiser PJ, Chiamvimonvat N, Periasamy M. 2007. Ablation of sarcolipin enhances sarcoplasmic reticulum calcium transport and atrial contractility. Proc. Natl. Acad. Sci. U. S. A. 104:17867-17872.
65. Davis W, Jr, Chen ZJ, Ile KE, Tew KD. 2003. Reciprocal regulation of expression of the human adenosine 5=-triphosphate binding cassette, subfamily A, transporter 2 (ABCA2) promoter by the early growth response-1 (EGR-1) and Sp-family transcription factors. Nucleic Acids Res. 31:1097-1107.
66. Huang RP, Fan Y, Ni Z, Mercola D, Adamson ED. 1997. Reciprocal modulation between Sp1 and Egr-1. J. Cell. Biochem. 66:489-499.
67. Zhang P, Tchou-Wong KM, Costa M. 2007. Egr-1 mediates hypoxiainducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter. Cancer Res. 67:9125-9133.
68. Bers DM. 2002. Cardiac excitation-contraction coupling. Nature 415: 198-205.
69. Handschin C, Rhee J, Lin J, Tarr PT, Spiegelman BM. 2003. An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle. Proc. Natl. Acad. Sci. U. S. A. 100:7111-7116.
70. Pogozelski AR, Geng T, Li P, Yin X, Lira VA, Zhang M, Chi JT, Yan Z. 2009. p38gamma mitogen-activated protein kinase is a key regulator in skeletal muscle metabolic adaptation in mice. PLoS One 4:e7934. doi:10.1371/journal.pone.0007934.
71. Puigserver P, Rhee J, Lin J, Wu Z, Yoon JC, Zhang CY, Krauss S, Mootha VK, Lowell BB, Spiegelman BM. 2001. Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Mol. Cell 8:971-982.
72. Andrews C, Ho PD, Dillmann WH, Glembotski CC, McDonough PM. 2003. The MKK6-p38 MAPK pathway prolongs the cardiac contractile calcium transient, downregulates SERCA2, and activates NF-AT. Cardiovasc. Res. 59:46-56.
73. Liao P, Georgakopoulos D, Kovacs A, Zheng M, Lerner D, Pu H, Saffitz J, Chien K, Xiao RP, Kass DA, Wang Y. 2001. The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy. Proc. Natl. Acad. Sci. U. S. A. 98:12283-12288.
74. Kho C, Lee A, Jeong D, Oh JG, Chaanine AH, Kizana E, Park WJ, Hajjar RJ. 2011. SUMO1-dependent modulation of SERCA2a in heart failure. Nature 477:601-605.
75. Bers DM. 2001. Excitation-contraction coupling and cardiac contractile force. Kluwer Academic Press, Dordrecht, The Netherlands.
76. 2+ uptake and impairs contractile function. J. Biol. Chem. 277:44740-44746.
77. 2++ transport and muscle relaxation in skeletal muscle from sarcolipin-null mice. Am. J. Physiol. Cell Physiol. 301:841-849.
78. Linossier MT, Denis C, Dormois D, Geyssant A, Lacour JR. 1993. Ergometric and metabolic adaptation to a 5-s sprint training programme. Eur. J. Appl. Physiol. Occup. Physiol. 67:408-414.
79. Russell AP, Feilchenfeldt J, Schreiber S, Praz M, Crettenand A, Gobelet C, Meier CA, Bell DR, Kralli A, Giacobino JP, Deriaz O. 2003. Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-gamma coactivator-1 and peroxisome proliferator-activated receptor-alpha in skeletal muscle. Diabetes 52:2874-2881.
80. 2+) leak as a novel therapeutic approach. Curr. Heart Fail. Rep. 4:11-17.
81. 2+-ATPase in patients with advanced heart failure. Circulation 124:304-313.
82. Akimoto T, Pohnert SC, Li P, Zhang M, Gumbs C, Rosenberg PB, Williams RS, Yan Z. 2005. Exercise stimulates Pgc-1alpha transcription in skeletal muscle through activation of the p38 MAPK pathway. J. Biol. Chem. 280:19587-19593.
83. Agilent Technologies, Inc. 2008. One-color microarray-based gene expression analysis (QuickAmplabeling) protocol: for use with Agilent gene expression oligonucleotide microarrays, version 5.7. Agilent Technologies, Inc., Santa Clara, CA.